InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Patent Reform Forum 2015 - Munich Agenda

September 8, Munich; September 10, Paris


Munich registration

September 8, Munich - The Charles Hotel

Paris registration

September 10, Paris - Paris Marriott Champs Elysees Hotel


FREE registration for in-house IP/patent counsel, general counsel and corporate executives



Agenda-Munich

Agenda- Paris

Speakers - Munich

Speakers - Paris

delegates Munich

Delegates - Paris



Contact us

Download the Munich agenda

08.00 Registration

08.35 Opening remarks by MIP

08.45 Keynote by Pierre Véron, partner, Véron & Associés

09.00 Detailed focus on the Unified Patent Court

  • Understanding the structure of the courts
  • Analysing evidence gathering and case management under the UPC
  • Examining how the courts will apply the drafted rules and what laws will the first decisions be based on?
  • Debating the pros and cons of bifurcation
  • Will the UPC remain a system outside of the EU framework?

Tim Whitfield, partner, Powell Gilbert
Pierre Véron,
partner, Véron & Associés
Thomas Bouvet,
partner, Véron & Associés

09.50 How to select the best litigation strategy for your business

  • Analysing the wide scope for forum shopping: risks and opportunities
  • Overcoming litigation shopping during transitional period
  • Strategies to defend yourself against forum shopping
  • Will the UPC provide a legitimate, respectable venue for patent litigation?

Huw Edwards, senior IPR litigation counsel, Nokia
Christian Heinze,
professor, University of Hanover
David Barron,
partner, Wragge Lawrence Graham & Co
Peter Koch,
partner, Wragge Lawrence Graham & Co

10.40 Coffee break

11.00 The Unitary Patent: Financial considerations

  • Overview of granting procedures and translation requirements under the Unitary Patent
  • Budgeting: how and when should you be preparing for the costs?
  • Examining the implications on your budget and strategies to prepare for any unexpected costs
  • Cost comparison: Unitary Patent versus European Patent versus National Patents

Stefan Luginbuehl, lawyer, international legal affairs, European Patent Office
Neil Trueman,
director of European IP strategy, Mundipharma International
Pierre Véron,
partner, Véron & Associés
Zoë Butler,
partner, Powell Gilbert
Tim Whitfield,
partner, Powell Gilbert

11.50 FOCUS: IT & Technology

  • Analysing the impact of the UPC on the IT and technology sector
  • Understanding tools for proceedings and claimant costs
  • Will the UPC have a positive impact on patent filing in the I.T. and technology sector?

Peter Wilson, patent attorney, BT
Graham Burnett-Hall,
partner, Marks & Clerk
Thomas Prock,
partner, Marks & Clerk

12.40 The impact of the UPC on life sciences

  • Concerns versus opportunities: understanding the risk of your patents in the transitional period
  • Examining how to obtain an injunction and the scope of liability
  • Evaluating the potential costs of a wrongly granted injunction
  • How suitable is the UPC for challenging patents?
  • Considerations to opt in or out?

Mark Chadwick, senior patent attorney, DSM
Martin Knauer,
German and European patent attorney, Roche Diagnostics
Joachim Feldges, partner, Allen & Overy
Mark Ridgway
, partner, Allen & Overy

13.30 Lunch

14.20 Alternative IP strategies parallel to the UPC

  • Understanding the rules of arbitration under the UPC
  • Examining the WIPO arbitration and mediation centre
  • Assessing when to use opposition proceedings
  • Is arbitration an attractive option under the new court system?

Heike Wollgast, senior legal officer, WIPO
Özge Moser,
legal counsel, HelmholtzZentrum München
Kay Kasper,
partner, ROKH IP
Willem Hoyng,
managing partner, Hoyng Monegier

15.10 Different systems: Poland, Spain & Switzerland

  • Understanding concerns and implications of the use of foreign languages in filing procedures and the geographical locations of proceedings
  • Identifying differences and opportunities: Swiss Patent Court vs UPC vs Intercontinental system
  • Does the UPC pose a threat to legal security?
  • Challenges and opportunities for patent owners using a system outside the UPC
  • Will the decision to join/opt out of the UPC be changed?
  • Looking to the future, e.g. will there be a new Spanish Patent Act?

Willem Hoyng, managing partner, Hoyng Monegier
Álvaro Velázquez, 
partner, Hoyng Monegier
Anna Sokołowska-Ławniczak
, senior associate and patent attorney, Traple Konarski Podrecki & Partners

16.00 Coffee break

16.20 Industry debate

  • Industry snapshot: How advanced should you be in preparing for the reform?
  • How do the costs influence decisions and potential usage of the courts?
  • Determining the success and adoption of the UPC
  • Opting out existing European Patents: pros and cons and how to plan a strategy
  • What are the likely costs - how does this change budgeting strategy?

Clemens Heusch, head of European litigation, Nokia
Colin Lamond,
intellectual property, Nissan Technical Europe
Dominic Adair,
partner, Bristows
Rachel Mumby,
associate, Bristows

17.10 Close of conference

Sponsors

Allen & Overy


Bristows


Marks & Clerk

Powell Gilbert ROKH
Valipat

Veron & Associes Wragge Lawrence Graham & Co


Supporting Organisations


European Patent Office

FICPI

CEIPI

profile

Managing IP

ManagingIP

ManagingIP profile

Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg

Dec 15 2017 10:12 ·  reply ·  retweet ·  favourite
ManagingIP profile

Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32

Dec 14 2017 09:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co

Dec 12 2017 10:22 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

End of Year 2017

Tribal sovereign immunity: Taking a wrecking ball to the IPR system

The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?



Most read articles

Supplements